| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/12/2012 | US20120010125 Methods, compounds and pharmaceutical compositions for treating anxiety and mood disorders |
| 01/12/2012 | US20120009288 Use of acacia extracts and their compounds on inhibition of xanthine oxidase |
| 01/12/2012 | US20120009283 Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions |
| 01/12/2012 | US20120009278 Composition To Retard the Onset of Symptoms of Alzheimer's Disease |
| 01/12/2012 | US20120009276 Composition for the treatment of oxidative stress |
| 01/12/2012 | US20120009272 Compositions and methods for creating an air release mechanism to maintain skin health |
| 01/12/2012 | US20120009268 Modified Virus Vectors and Methods of Making and Using the Same |
| 01/12/2012 | US20120009267 Nanoparticle compositions and methods for improved oral delivery of active agents |
| 01/12/2012 | US20120009266 Composition comprising ocaperidone |
| 01/12/2012 | US20120009264 Drug carrier for treating of gastrointestinal ulcer |
| 01/12/2012 | US20120009262 Medical apparatus and method for producing same |
| 01/12/2012 | US20120009261 Novel gastro-retentive dosage forms |
| 01/12/2012 | US20120009259 Formulation for co-therapy treatment of diabetes |
| 01/12/2012 | US20120009258 Compacted cinacalcet |
| 01/12/2012 | US20120009257 Galenical Formulations of a Fixed Dose Combination of Valsartan and Aliskiren |
| 01/12/2012 | US20120009255 Methods of treating infectious diseases |
| 01/12/2012 | US20120009253 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds of the lower respiratory tract |
| 01/12/2012 | US20120009252 Liposomal formulations of anthracycline agents and cytidine analogs |
| 01/12/2012 | US20120009251 Cholestanol derivative for combined use |
| 01/12/2012 | US20120009250 Controlled release delivery system for nasal applications |
| 01/12/2012 | US20120009249 Controlled release delivery system for nasal application of neurotransmitters |
| 01/12/2012 | US20120009248 Preservation of Bioactive Materials By Spray Drying |
| 01/12/2012 | US20120009247 Phospholipid drug analogs |
| 01/12/2012 | US20120009246 Phospholipid-analogous compounds |
| 01/12/2012 | US20120009244 NEUROD1 GENE EXPRESSION IN NON-ENDOCRINE PANCREATIC EPITHELIAL CELLS (NEPECs) |
| 01/12/2012 | US20120009243 Liposomes for drug delivery and methods for preparation thereof |
| 01/12/2012 | US20120009242 Blood coagulation inducing polymer hydrogel |
| 01/12/2012 | US20120009241 Skin wound dressing and preparing method thereof |
| 01/12/2012 | US20120009240 Films for Delivery of a Therapeutic Agent |
| 01/12/2012 | US20120009239 Prebiotic Formulations for use with Probiotics to Increase Probiotic Growth Rate and Activity |
| 01/12/2012 | US20120009235 Stabilized peeling capsule |
| 01/12/2012 | US20120009228 Prebiotic Compositions for use with Probiotics to Increase Probiotic Growth Rate and Activity |
| 01/12/2012 | US20120009227 Active coating of pharmaceutical dosage forms |
| 01/12/2012 | US20120009226 Highly pure laquinimod or a pharmaceutically acceptable salt thereof |
| 01/12/2012 | US20120009223 COLLAGEN-BASED HYDROGELS LOADED WITH ZnO QDs/pDNA COMPLEXES AS CORNEAL SUBSTITUES |
| 01/12/2012 | US20120009222 Modulation of the immune response |
| 01/12/2012 | US20120009216 Early detection of flaviviruses using the ns1 glycoprotein |
| 01/12/2012 | US20120009206 Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity |
| 01/12/2012 | US20120009203 Depletion of cancer stem cells |
| 01/12/2012 | US20120009202 Target host factors for treating viral infection |
| 01/12/2012 | US20120009201 Renal cell carcinoma biomarkers |
| 01/12/2012 | US20120009195 Antibody neutralizers of human granulocyte macrophage colony stimulating factor |
| 01/12/2012 | US20120009190 Identification and method for using the pre-ligand assembly domain of the il-17 receptor |
| 01/12/2012 | US20120009187 Cloning and recombinant productions of vespula venom protease and methods of use thereof |
| 01/12/2012 | US20120009183 Method for treatment of pancreatitis |
| 01/12/2012 | US20120009174 Biomarkers for myocardial ischemia |
| 01/12/2012 | US20120009172 Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitor |
| 01/12/2012 | US20120009170 METHOD OF TREATING INFLAMMATORY LUNG DISEASE WITH SUPPRESSORS OF CpG OLIGONUCLEOTIDES |
| 01/12/2012 | US20120009169 Self-forming phospholipidic gels |
| 01/12/2012 | US20120009168 Improved emulsifying system for nutraceutical compositions |
| 01/12/2012 | US20120009162 T cell receptor and nucleic acid encoding the receptor |
| 01/12/2012 | US20120009152 Nitric oxide donors for treatment of disease and injury |
| 01/12/2012 | US20120009151 Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof |
| 01/12/2012 | US20120009150 Diaryl ureas for treating virus infections |
| 01/12/2012 | US20120009147 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 01/12/2012 | US20120009145 Biodegradable Cross-Linked Cationic Multi-block Copolymers for Gene Delivery and Methods of Making Thereof |
| 01/12/2012 | US20120009144 Heterocyclic antiviral compounds |
| 01/12/2012 | US20120009142 Methods for treating hepatitis c |
| 01/12/2012 | US20120009141 Functionalized pyrrolidines and use thereof as iap inhibitors |
| 01/12/2012 | US20120009139 Methods and Compositions for Promoting Organ Development |
| 01/12/2012 | US20120009132 Transparent Xyloglucan/Chitosan Gel and a Process for the Preparation Thereof |
| 01/12/2012 | US20120009131 Method for preventing or treating amyloid beta peptide-associated diseases or conditions, and method for inhibiting formation, accumulation or aggregation of amyloid beta peptides |
| 01/12/2012 | US20120009130 Viral Therapy and Prophylaxis Using Nanotechnology Delivery Techniques |
| 01/12/2012 | US20120006748 Buffered compositions for dialysis |
| 01/12/2012 | DE102010031149A1 New 1H-pyrazolo(3,4-b)pyridine compounds are guanylate cyclase stimulators useful to treat and/or prevent heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, and vascular disease |
| 01/12/2012 | DE102010031148A1 New 1-(2-fluoro-benzyl)-1H-pyrazolo(3,4-b)pyridine compounds are guanylate cyclase stimulators useful to treat and/or prevent heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, and vascular disease |
| 01/12/2012 | DE102010026903A1 Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff Transdermal therapeutic system with avocado oil or palm oil as an adjuvant |
| 01/12/2012 | CA2805568A1 Oral dosage form of deferasirox |
| 01/12/2012 | CA2805452A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators |
| 01/12/2012 | CA2805065A1 Indolizine derivatives, process for the preparation thereof and therapeutic use thereof |
| 01/12/2012 | CA2804989A1 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and uses thereof |
| 01/12/2012 | CA2804986A1 Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof |
| 01/12/2012 | CA2804940A1 Process for the synthesis of substituted morphinans |
| 01/12/2012 | CA2804926A1 Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
| 01/12/2012 | CA2804924A1 Substituted pyridine compound |
| 01/12/2012 | CA2804918A1 N-hydroxyformamide derivative and medicament containing same |
| 01/12/2012 | CA2804915A1 Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof |
| 01/12/2012 | CA2804874A1 Formulations comprising coated fine particles |
| 01/12/2012 | CA2804789A1 Pkc activators and anticoagulant in regimen for treating stroke |
| 01/12/2012 | CA2804666A1 Methods of immune modulation |
| 01/12/2012 | CA2804648A1 Protein kinase inhibitors and methods of treatment |
| 01/12/2012 | CA2804599A1 Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway |
| 01/12/2012 | CA2804593A1 Biphenyloxybenzensulphonamide derivatives |
| 01/12/2012 | CA2804506A1 Formulation for co-therapy treatment of diabetes |
| 01/12/2012 | CA2804473A1 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate (s1p) receptors |
| 01/12/2012 | CA2804471A1 Ring-fused 4 -aminopyrimidines and use thereof as stimulators of soluable guanylate cyclases |
| 01/12/2012 | CA2804470A1 Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases |
| 01/12/2012 | CA2804358A1 Pharmaceutical compositions containing vanoxerine |
| 01/12/2012 | CA2804341A1 Time-delayed sustained release pharmaceutical composition comprising dapoxetine for oral administration |
| 01/12/2012 | CA2804334A1 Xanthenedione derivatives for the treatment of pigmentation and skin ageing disorders |
| 01/12/2012 | CA2804329A1 Bisaryl (thio)morpholine derivatives as s1p modulators |
| 01/12/2012 | CA2804285A1 Bipyridyl derivatives useful for the treatment of kinase - induced diseases |
| 01/12/2012 | CA2804271A1 Prophylactic or therapeutic agent for diabetes |
| 01/12/2012 | CA2804214A1 Methods and compositions for the specific inhibition of beta-catenin by double-stranded rna |
| 01/12/2012 | CA2804210A1 Methods and compositions for the specific inhibition of androgen receptor by double-stranded rna |
| 01/12/2012 | CA2804177A1 Novel quinoline esters useful for treating skin disorders |
| 01/12/2012 | CA2804173A1 Sulfonamide nav1.7 inhibitors |
| 01/12/2012 | CA2804165A1 Piperidinyl pyrimidine amides as kv7 potassium channel openers |
| 01/12/2012 | CA2804161A1 Pro-neurogenic compounds |
| 01/12/2012 | CA2804144A1 Multi-component pharmaceuticals for treating diabetes |